Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Sibamed GmbH & Co. KG

Leipzig, 04103, GermanyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Atopic dermatitis (eczema)

Closed trials

Completed
Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO)
2022-501586-50-00· Phase 3· Amgen Inc.· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 5 Nov 2026

Report an error

Under construction, not live – Sibamed GmbH & Co. KG: trial site – Frontlight Research